Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Armata Pharmaceuticals, Inc. | v466204_ex5-1.htm |
| S-1MEF - S-1MEF - Armata Pharmaceuticals, Inc. | v466204_s1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-1 filed pursuant to Rule 462(b) of the Securities Act of 1933 of the reference to our firm under the caption “Experts” and to the incorporation by reference of our report dated March 27, 2017, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation incorporated by reference in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-217169) and related Prospectus of AmpliPhi Biosciences Corporation for the registration of its common stock and warrants to purchase shares of its common stock.
/s/ Ernst & Young LLP
San Diego, California
May 4, 2017